Cargando…
EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis
Eph receptors and their ligands (ephrins) play an important role in axonal guidance, topographic mapping, and angiogenesis. The signaling pathways mediating these activities are starting to emerge and are highly cell- and receptor-type specific. Here we demonstrate that activated EphB1 recruits the...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173797/ https://www.ncbi.nlm.nih.gov/pubmed/12925710 http://dx.doi.org/10.1083/jcb.200302073 |
_version_ | 1782145254069108736 |
---|---|
author | Vindis, Cécile Cerretti, Douglas Pat Daniel, Thomas O. Huynh-Do, Uyen |
author_facet | Vindis, Cécile Cerretti, Douglas Pat Daniel, Thomas O. Huynh-Do, Uyen |
author_sort | Vindis, Cécile |
collection | PubMed |
description | Eph receptors and their ligands (ephrins) play an important role in axonal guidance, topographic mapping, and angiogenesis. The signaling pathways mediating these activities are starting to emerge and are highly cell- and receptor-type specific. Here we demonstrate that activated EphB1 recruits the adaptor proteins Grb2 and p52(Shc) and promotes p52(Shc) and c-Src tyrosine phosphorylation as well as MAPK/extracellular signal–regulated kinase (ERK) activation. EphB1-mediated increase of cell migration was abrogated by the MEK inhibitor PD98059 and Src inhibitor PP2. In contrast, cell adhesion, which we previously showed to be c-jun NH2-terminal kinase (JNK) dependent, was unaffected by ERK1/2 and Src inhibition. Expression of dominant-negative c-Src significantly reduced EphB1-dependent ERK1/2 activation and chemotaxis. Site-directed mutagenesis experiments demonstrate that tyrosines 600 and 778 of EphB1 are required for its interaction with c-Src and p52(Shc). Furthermore, phosphorylation of p52(Shc) by c-Src is essential for its recruitment to EphB1 signaling complexes through its phosphotyrosine binding domain. Together these findings highlight a new aspect of EphB1 signaling, whereby the concerted action of c-Src and p52(Shc) activates MAPK/ERK and regulates events involved in cell motility. |
format | Text |
id | pubmed-2173797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21737972008-05-01 EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis Vindis, Cécile Cerretti, Douglas Pat Daniel, Thomas O. Huynh-Do, Uyen J Cell Biol Article Eph receptors and their ligands (ephrins) play an important role in axonal guidance, topographic mapping, and angiogenesis. The signaling pathways mediating these activities are starting to emerge and are highly cell- and receptor-type specific. Here we demonstrate that activated EphB1 recruits the adaptor proteins Grb2 and p52(Shc) and promotes p52(Shc) and c-Src tyrosine phosphorylation as well as MAPK/extracellular signal–regulated kinase (ERK) activation. EphB1-mediated increase of cell migration was abrogated by the MEK inhibitor PD98059 and Src inhibitor PP2. In contrast, cell adhesion, which we previously showed to be c-jun NH2-terminal kinase (JNK) dependent, was unaffected by ERK1/2 and Src inhibition. Expression of dominant-negative c-Src significantly reduced EphB1-dependent ERK1/2 activation and chemotaxis. Site-directed mutagenesis experiments demonstrate that tyrosines 600 and 778 of EphB1 are required for its interaction with c-Src and p52(Shc). Furthermore, phosphorylation of p52(Shc) by c-Src is essential for its recruitment to EphB1 signaling complexes through its phosphotyrosine binding domain. Together these findings highlight a new aspect of EphB1 signaling, whereby the concerted action of c-Src and p52(Shc) activates MAPK/ERK and regulates events involved in cell motility. The Rockefeller University Press 2003-08-18 /pmc/articles/PMC2173797/ /pubmed/12925710 http://dx.doi.org/10.1083/jcb.200302073 Text en Copyright © 2003, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Vindis, Cécile Cerretti, Douglas Pat Daniel, Thomas O. Huynh-Do, Uyen EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis |
title | EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis |
title_full | EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis |
title_fullStr | EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis |
title_full_unstemmed | EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis |
title_short | EphB1 recruits c-Src and p52(Shc) to activate MAPK/ERK and promote chemotaxis |
title_sort | ephb1 recruits c-src and p52(shc) to activate mapk/erk and promote chemotaxis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173797/ https://www.ncbi.nlm.nih.gov/pubmed/12925710 http://dx.doi.org/10.1083/jcb.200302073 |
work_keys_str_mv | AT vindiscecile ephb1recruitscsrcandp52shctoactivatemapkerkandpromotechemotaxis AT cerrettidouglaspat ephb1recruitscsrcandp52shctoactivatemapkerkandpromotechemotaxis AT danielthomaso ephb1recruitscsrcandp52shctoactivatemapkerkandpromotechemotaxis AT huynhdouyen ephb1recruitscsrcandp52shctoactivatemapkerkandpromotechemotaxis |